Simplex Trading
AVIR icon

Simplex Trading’s Atea Pharmaceuticals AVIR Stock Holding History

Simplex Trading’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.6K Buy
5,500
+900
+20% +$4.48K ﹤0.01% 6889
2026
Q1 		$24.7K Buy
4,600
+1,900
+70% +$8.73K ﹤0.01% 6593
2025
Q4 		$9.64K Buy
2,700
+400
+17% +$1.27K ﹤0.01% 7007
2025
Q3 		$6K Buy
2,300
+300
+15% +$1.02K ﹤0.01% 8156
2025
Q2 		$7K Sell
2,000
-1,400
-41% -$4.17K ﹤0.01% 7526
2025
Q1 		$10K Sell
3,400
-13,900
-80% -$43.4K ﹤0.01% 7070
2024
Q4 		$57K Buy
17,300
+1,800
+12% +$5.98K ﹤0.01% 5739
2024
Q3 		$51K Sell
15,500
-2,400
-13% -$8.7K ﹤0.01% 5854
2024
Q2 		$59K Buy
17,900
+7,500
+72% +$28K ﹤0.01% 5903
2024
Q1 		$42K Buy
+10,400
New +$40.7K ﹤0.01% 6408
2023
Q3 		– Sell
-1,100
Closed -$4K – 8630
2023
Q2 		$4K Sell
1,100
-9,900
-90% -$37.1K ﹤0.01% 8004
2023
Q1 		$36K Sell
11,000
-230,600
-95% -$935K ﹤0.01% 6282
2022
Q4 		$1.16M Sell
241,600
-66,800
-22% -$338K ﹤0.01% 2325
2022
Q3 		$1.75M Buy
308,400
+29,800
+11% +$228K ﹤0.01% 2074
2022
Q2 		$1.98M Buy
278,600
+243,800
+701% +$1.66M ﹤0.01% 1879
2022
Q1 		$251K Sell
34,800
-12,900
-27% -$87.6K ﹤0.01% 4804
2021
Q4 		$426K Buy
47,700
+42,200
+767% +$658K ﹤0.01% 4038
2021
Q3 		$117K Hold
5,500
– – ﹤0.01% 6391
2021
Q2 		$118K Buy
5,500
+5,471
+18,866% +$164K ﹤0.01% 6483
2021
Q1 		$179K Buy
+29
New +$1.96K ﹤0.01% 4910

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Simplex Trading's AVIR Position: Q2 2026 in Review

Simplex Trading reduced its Atea Pharmaceuticals (AVIR) stake by 53% in Q2 2026, selling an estimated $16.5K and leaving 2,933 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #7436.

Simplex Trading first reported a position in AVIR in Q4 2021 and has held it in 15 quarters since. The position peaked at $847K in Q1 2022. 125 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

  • Simplex Trading held 2,933 shares of Atea Pharmaceuticals worth $13.6K as of Q2 2026.
  • Simplex Trading sold 3,311 Atea Pharmaceuticals shares in Q2 2026, an estimated $16.5K.
  • Atea Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7436 holding.
  • Simplex Trading first reported a position in Atea Pharmaceuticals in Q4 2021 and has held it in 15 quarters since.
  • Simplex Trading's Atea Pharmaceuticals position peaked at $847K in Q1 2022.
  • 125 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.